ARCHIVES

FDA cancer therapeutics review split among three units in reorganization.

This article is from The Cancer Letter archive.

Vol. 29 No. 37 | October 10, 2003

Download PDF Visit The Full Archive

Related Articles

Breast MRI Recipients More Likely To Choose Mastectomy

July 31, 2009

Virus Working Group Suggests 14 Projects As Suitable For New Contract Proposals

March 1, 1974

DCPC BSC Committee Endorses Three Research Concepts

April 17, 1987

Kessler Promises Cancer Patient Liaison In FDA; Considers Joint Drugs, Biologics Oncology Review

August 14, 1992

New ACS Awards Total $18.4 Million

February 23, 1979

Lapatinib Improves Outcome Of Advanced Breast Cancer

July 28, 2006